BCI Market Size: $2.94B ▲ +16.8% CAGR | Cognitive Computing: $48.88B ▲ +22.3% CAGR | Deep Learning Market: $34.28B ▲ +27.8% CAGR | Global AI Market: $390.9B ▲ +30.6% CAGR | Neuralink Implants: 3 Patients | AGI Median Forecast: 2040 | BCI Healthcare Share: 58.5% | Non-Invasive BCI: 81.9% | BCI Market Size: $2.94B ▲ +16.8% CAGR | Cognitive Computing: $48.88B ▲ +22.3% CAGR | Deep Learning Market: $34.28B ▲ +27.8% CAGR | Global AI Market: $390.9B ▲ +30.6% CAGR | Neuralink Implants: 3 Patients | AGI Median Forecast: 2040 | BCI Healthcare Share: 58.5% | Non-Invasive BCI: 81.9% |

Entities

Anthropic — Entity Profile & AI Safety Research

Profile of Anthropic examining its constitutional AI approach, Claude model family, AI safety research, and AI welfare initiatives.

Updated Mar 25, 2026

Blackrock Neurotech — Entity Profile & Utah Array Legacy

Profile of Blackrock Neurotech examining its Utah Array technology, BrainGate program legacy, and next-generation neural interface development.

Updated Mar 25, 2026

Emotiv — Entity Profile & Consumer EEG Systems

Profile of Emotiv examining its EPOC and Insight EEG headsets, brain-controlled computing applications, and the consumer neurotechnology market.

Updated Mar 25, 2026

Google DeepMind — Entity Profile & AI Research Analysis

Profile of Google DeepMind examining its AI research breakthroughs, the Titans architecture, AGI research program, and strategic positioning.

Updated Mar 25, 2026

Neuralink Corporation — Complete Entity Profile

Comprehensive profile of Neuralink Corporation, examining its N1 brain-computer interface implant, clinical trials, funding trajectory, patent portfolio, and competitive positioning in the BCI market.

Updated Mar 25, 2026

OpenAI — Entity Profile & Research Program

Profile of OpenAI examining its GPT model family, AGI mission, preparedness framework, and competitive positioning.

Updated Mar 25, 2026

Paradromics — Entity Profile & Connexus BCI System

Profile of Paradromics examining its Connexus high-channel-count BCI, FDA IDE approval, and the Connect-One clinical study.

Updated Mar 25, 2026

Synchron Inc. — Entity Profile & Stentrode Analysis

Profile of Synchron Inc., its endovascular Stentrode BCI, clinical trials, NVIDIA AI integration, and the Chiral cognitive foundation model roadmap.

Updated Mar 25, 2026
Layer 2 Intelligence

Access premium analysis for this section.

Subscribe →

Institutional Access

Coming Soon